Association of NT-proBNP With Clinical Outcomes in Patients Undergoing Transcatheter Tricuspid Valve Intervention
Athanasios Feidakis, Jan Althoff, Thorsten Gietzen, Laura Marx, Caroline Hasse, Jennifer von Stein, Maria I Körber, Stephan Baldus, Roman Pfister, Christos Iliadis · 2026
Read Association of NT-proBNP With Clinical Outcomes in Patients Undergoing Transcatheter Tricuspid Valve Intervention by Athanasios Feidakis, Jan Althoff, Thorsten Gietzen, Laura Marx, Caroline Hasse, Jennifer von Stein, Maria I Körber, Stephan Baldus, Roman Pfister, Christos Iliadis (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13311164.txt.
Description
Athanasios Feidakis and colleagues test a heart strain marker in tricuspid valve catheter care in a 2026 study. NT-proBNP sorts risk in heart failure well, yet its value before and after tricuspid valve intervention was unclear. Patients with severe valve leak were grouped by starting marker levels and by early change.
Higher starting levels linked on their own to higher long term death rates. Patients whose marker rose by four weeks fared far worse, whatever the procedure result. Rising marker patients also held larger right heart chambers and higher pressures at start. Starting level did not foretell symptom gain at four weeks.
Catalog record
| CREATOR | Athanasios Feidakis, Jan Althoff, Thorsten Gietzen, Laura Marx, Caroline Hasse, Jennifer von Stein, Maria I Körber, Stephan Baldus, Roman Pfister, Christos Iliadis |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55015 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |